Jazz Pharmaceuticals (JAZZ) Debt Ratio (2010 - 2026)
Jazz Pharmaceuticals' quarterly Debt Ratio came in at 0.45 in Q1 2026, down 2.97% year-on-year from 0.47 in Q1 2025, and down 1.75% quarter-over-quarter from 0.46 in Q4 2025.
Jazz Pharmaceuticals has reported Debt Ratio for 17 years, with the latest figure at 0.45 in Q1 2026.
- For the quarter ending Q1 2026, Debt Ratio fell 2.97% year-over-year to 0.45; the trailing twelve-month figure through Mar 2026 stood at 0.45 (down 2.97% YoY), and the FY2025 full-year result was 0.46, down 9.63% from the prior year.
- Debt Ratio for Q1 2026 stood at 0.45, down from 0.46 in the prior quarter.
- The five-year high for Debt Ratio was 0.55 in Q3 2022, with the low at 0.45 in Q1 2026.
- Average Debt Ratio over 5 years is 0.5, with a median of 0.5 recorded in 2024.
- Year-over-year, Debt Ratio surged 64.55% in 2022 and retreated 9.63% in 2025.
- Tracing JAZZ's Debt Ratio over 5 years: stood at 0.53 in 2022, then dropped by 5.09% to 0.5 in 2023, then rose by 1.42% to 0.51 in 2024, then slipped by 9.63% to 0.46 in 2025, then dropped by 1.75% to 0.45 in 2026.
- The last three Debt Ratio figures came in at 0.45 (Q1 2026), 0.46 (Q4 2025), and 0.47 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.18 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 1.41 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.05 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | 0.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.45 |
| Dec 31, 2025 | 0.46 |
| Sep 30, 2025 | 0.47 |
| Jun 30, 2025 | 0.49 |
| Mar 31, 2025 | 0.47 |
| Dec 31, 2024 | 0.51 |
| Sep 30, 2024 | 0.50 |
| Jun 30, 2024 | 0.50 |
| Mar 31, 2024 | 0.50 |
| Dec 31, 2023 | 0.50 |
| Sep 30, 2023 | 0.51 |
| Jun 30, 2023 | 0.51 |
| Mar 31, 2023 | 0.52 |
| Dec 31, 2022 | 0.53 |
| Sep 30, 2022 | 0.55 |
| Jun 30, 2022 | 0.54 |
| Mar 31, 2022 | 0.51 |
| Dec 31, 2021 | 0.49 |
| Sep 30, 2021 | 0.50 |
| Jun 30, 2021 | 0.51 |
| Mar 31, 2021 | 0.31 |
| Dec 31, 2020 | 0.32 |
| Sep 30, 2020 | 0.33 |
| Jun 30, 2020 | 0.35 |
| Mar 31, 2020 | 0.31 |
| Dec 31, 2019 | 0.29 |
| Sep 30, 2019 | 0.29 |
| Jun 30, 2019 | 0.29 |
| Mar 31, 2019 | 0.30 |
| Dec 31, 2018 | 0.31 |
| Sep 30, 2018 | 0.29 |
| Jun 30, 2018 | 0.30 |
| Mar 31, 2018 | 0.30 |
| Dec 31, 2017 | 0.31 |
| Sep 30, 2017 | 0.32 |
| Jun 30, 2017 | 0.35 |
| Mar 31, 2017 | 0.39 |
| Dec 31, 2016 | 0.42 |
| Sep 30, 2016 | 0.44 |
| Jun 30, 2016 | 0.34 |
| Mar 31, 2016 | 0.33 |
| Dec 31, 2015 | 0.36 |
| Sep 30, 2015 | 0.37 |
| Jun 30, 2015 | 0.40 |
| Mar 31, 2015 | 0.42 |
| Dec 31, 2014 | 0.40 |
| Sep 30, 2014 | 0.40 |
| Jun 30, 2014 | 0.38 |
| Mar 31, 2014 | 0.37 |
| Dec 31, 2013 | 0.25 |
| Sep 30, 2013 | 0.25 |
| Jun 30, 2013 | 0.26 |
| Mar 31, 2013 | 0.22 |
| Dec 31, 2012 | 0.23 |
| Sep 30, 2012 | 0.27 |
| Jun 30, 2012 | 0.28 |
| Jun 30, 2011 | 0.02 |
| Dec 31, 2010 | 0.35 |